Synthesis and In Vitro Cytotoxicity of 2-Alkylaminosubstituted Quinoline Derivatives

Archives of Pharmacal Research

Volumn 23, Issue 5, 2000, Pages 450-454

  Lee, Heesoon ^a   Lee, Jeeman ^a   Hong, Seoung Soo ^a   Yang, Sung Il ^b   Jung, Sang Hun ^c   Jahng, Yurngdong ^d   Cho, Jungsook ^e  

^a Chungbuk National University   (South Korea)

^b Konkuk University   (South Korea)

^c Chungnam National University   (South Korea)

^d Yeungnam University   (South Korea)

^e Dongguk University College of Medicine   (South Korea)

Author keywords

Antitumor agents; Cytotoxic activity; Doxorubicin; TAS 103

Indexed keywords

ANTINEOPLASTIC AGENT; QUINOLINE DERIVATIVE;

ARTICLE; CELL CULTURE; HUMAN; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTINEOPLASTIC AGENTS; HUMANS; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0034305372     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976570     Document Type: Article

References (7)

1. Alvarez-Ibarra, C., Fernandez-Cranda, R., Quiroga, M. L., Carbonell, A., Cardenas, F., and Cirait, E. Synthesis and Antitumor Evaluation of New Thiazolo[5,4-b]quinoline Derivatives. J. Med. Chem. 40, 668-676 (1997) and references cited therein.
2. Aoyagi, Y., Kobunai, T., Utsugi, T., Oh-hara, T., Yamada, Y., In vitro antitumor activity of TAS-103, a novel quinoline derivative that targets topoisomerases I and II. Jpn. J. Cancer Res. 90, 578-587, (1999) and references cited therein.
3. Kaslow, C. E., Sommer, N. B., Substituted Lepidines, J. Am. Chem. Soc., 68, 644-646 (1946).
4. Minderman, H., Wrzosek, C., Cao, S. S., Utsugi, T., Kobunai, T., Yamada, Y., Rustum, Y. M., Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells. Cancer Chemother. Pharmacol. 45, 78-84 (2000) and references cited therein.
5. Peacocke, A. R. In Heterocyclic Compounds: The Acridines; Acheson, R. M., Ed.; Wiley Interscience: New York, (1973).
6. Potts, K. T., Bhattachaarjee, D., and Walsh E. B., Cycloaddition Routes to Azaanthraquinone Derivatives. 1. Use of Azadienophiles. J. Org. Chem. 51, 2011-2021 (1986).
7. Skehan, P., Storeng, R., Scudiero, D, Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenny, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990).